cenderitide

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2016
012320112016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Millions of patients worldwide are admitted for acute heart failure (AHF) each year and physicians caring for these patients are… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2017
2017
Cenderitide is a novel designer natriuretic peptide (NP) composed of C-type natriuretic peptide (CNP) fused to the C-terminus of… (More)
  • table 2
  • table 3
Is this relevant?
2016
2016
AIMS Cenderitide is a novel dual natriuretic peptide (NP) receptor chimeric peptide activator, which targets the particulate… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2014
2014
Despite the success that drug-eluting stents (DESs) have achieved for minimizing in-stent restenosis (ISR), the antirestenotic… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2014
2014
In this work, we focused on the development and investigation of controlled release matrices for a novel cardiotherapeutic… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Cenderitide, also known as CD-NP, is a designer peptide developed by combining native mammalian c-type natriuretic peptide (CNP… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
Natriuretic peptides (NPs) are cardioprotective through the activation of guanylyl cyclase (GC) receptors A and B. CD-NP, also… (More)
  • figure 1
  • figure 3
  • figure 2
  • table 1
  • figure 4
Is this relevant?
2011
2011
Background Patients with congestive heart failure (HF) have symptomatic improvement with diuretic therapy, although with time… (More)
Is this relevant?
2011
2011
Background Cenderitide, also known as CD-NP, is a novel Mayo engineered designer natriuretic peptide (NP), which unlike native… (More)
Is this relevant?
2011
2011
Background Heart failure (HF) remains a therapeutic challenge with high morbidity and mortality and frequent hospitalizations… (More)
Is this relevant?